Omega-3 fatty acids exert several important biological effects on fact
ors that may predispose to diabetic retinopathy. Potential pathogeneti
c mechanisms include platelet dysfunction, altered eicosanoid producti
on, increased blood viscosity in association with impaired cell deform
ability and pathologic leucocyte/endothelium interaction. Therefore, w
e tested whether a 6-month administration of fish oil (750 mg Maxepa,
5 times per week), containing 14% eicosapentaenoic acid (EPA) and 10%
docosahexaenic acid, could inhibit the development of experimental ret
inopathy of the streptozotocin-diabetic rat. The efficiency of fish oi
l supplementation was evaluated by measuring EPA concentrations in tot
al, plasma and membrane fatty acids and by measuring the generation of
lipid mediators (leukotrienes and thromboxanes). Retinal digest prepa
rations were quantitatively analysed for pericyte loss, and the format
ion of acellular capillaries. Omega-3 fatty acid administration to dia
betic rats resulted in a twofold increase of EPA 20:5 in total fatty a
cids, and a reduction of the thromboxane(2/3) ratio from 600 (untreate
d diabetic rats) to 50 (treated diabetic rats). Despite these biochemi
cal changes, diabetes-associated pericyte loss remained unaffected and
the formation of acellular, occluded capillaries was increased by 75%
in the fish oil treated diabetic group (115.1 +/- 26.8; untreated dia
betic 65.2 +/- 15.0 acellular capillary segments/mm(2) of retinal area
). We conclude from this study that dietary fish oil supplementation m
ay be harmful for the diabetic microvasculature in the retina.